• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kyverna Therapeutics, Inc. - Common Stock (NQ: KYTX )

    5.120 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 27
    Open 5.120
    Bid (Size) 5.120 (2)
    Ask (Size) 5.650 (5)
    Prev. Close 5.120
    Today's Range 5.120 - 5.120
    52wk Range 4.400 - 35.06
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
    Amgen tested its drug, Uplizna, in generalized myasthenia gravis, a market where Argenx's Vyvgart leads. 
    Via Investor's Business Daily
    Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga

    Performance

    YTD
    -82.93%
    -82.93%
    1 Month
    -2.10%
    -2.10%
    3 Month
    -45.88%
    -45.88%
    6 Month
    -65.89%
    -65.89%
    1 Year
    -82.93%
    -82.93%

    More News

    Read More
    Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    KYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q2 2024
    Via InvestorPlace
    Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges
    Via Benzinga
    Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    KYTX Investors Have Opportunity to Join Kyverna Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Why Kyverna Therapeutics Stock Is Sinking
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Dow Tumbles Over 200 Points; Adobe Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    KYTX Stock Earnings: Kyverna Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
    Via The Motley Fool
    Topics Initial Public Offering
    Exposures Securities Market
    Gilead-Backed Kyverna Overshoots Raised IPO Expectations
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.